skip to Main Content

Pharmacogenomics: Lowering costs, improving outcomes through personalized medicine

Webinar Date: August 7, 2019 1:00 pm

Pharmacogenomics considers the role of the genome in drug response. It combines pharmacology and genomics, considering how the genetic makeup of an individual affects his/her response to drugs.

Today, more than ever before, we have the ability to target the right drug to improve a patient’s quality of life while also eliminating waste from non-optimized medications. This webinar provided an overview of pharmacogenomics and showcased an employer case example of the opportunities and savings available to employers and health plans through integration of personalized medicine into benefit plan design.

Featuring the voices of Jane Cheshire Gilbert, CPA, director of retiree health care for the Teachers’ Retirement System of the State of Kentucky and Steve Goldberg, MD, vice president, medical affairs, population health and chief health officer, health & wellness, Quest Diagnostics, GTMRx Institute board member.


Steven Goldberg

Steven Goldberg, MD, MBA

VP, Medical Affairs, Population Health, Chief Health Officer, Health and Wellness
Quest Diagnostics

Jane Cheshire Gilbert, CPA

Director, Retiree Health Care
Teachers’ Retirement System of the State of Kentucky (TRS)
Back To Top
×Close search

We need your help now more than ever!